Medindia
Medindia LOGIN REGISTER
Advertisement

BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU

Tuesday, August 17, 2010 Research News
Advertisement
Contacts:

Investors

Media

Eugenia Shen

Susan Berg

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc

(415) 506-6570

(415) 506-6594

Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close